Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242085 | SCV000317065 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000242085 | SCV000532854 | benign | not specified | 2016-11-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000560640 | SCV000653955 | benign | Congenital myasthenic syndrome 8 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000242085 | SCV001880897 | benign | not specified | 2020-09-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002262910 | SCV002543833 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | AGRN: BP4, BP7, BS2 |
Fulgent Genetics, |
RCV000560640 | SCV002806526 | likely benign | Congenital myasthenic syndrome 8 | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002262910 | SCV005284350 | benign | not provided | criteria provided, single submitter | not provided |